Christopher Lincoln

Person

La Canada, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Compound for treating cancer and diabetes
- Patent number 11,583,509
- Issue date Feb 21, 2023
- City of Hope
- Samuel Rahbar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ribonucleotide reductase inhibitors and methods of use
- Patent number 10,155,732
- Issue date Dec 18, 2018
- City of Hope
- David Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Modulators of development of adipocyte and cancer cells
- Patent number 10,029,991
- Issue date Jul 24, 2018
- City of Hope
- Samuel Rahbar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isatin derivatives, pharmaceutical compositions thereof, and method...
- Patent number 9,828,342
- Issue date Nov 28, 2017
- City of Hope
- David A. Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compound for treating cancer and diabetes
- Patent number 9,808,434
- Issue date Nov 7, 2017
- City of Hope
- Samuel Rahbar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ribonucleotide reductase inhibitors and methods of use
- Patent number 9,796,692
- Issue date Oct 24, 2017
- City of Hope
- David Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ribonucleotide reductase inhibitors and methods of use
- Patent number 9,598,385
- Issue date Mar 21, 2017
- City of Hope
- David Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ribonucleotide reductase inhibitors and methods of use
- Patent number 9,126,960
- Issue date Sep 8, 2015
- City of Hope
- David Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ribonucleotide reductase inhibitors and methods of use
- Patent number RE45020
- Issue date Jul 15, 2014
- City of Hope
- David Horne
- 548 - Organic compounds
Information Patent Grant
Ribonucleotide reductase inhibitors and methods of use
- Patent number 8,372,983
- Issue date Feb 12, 2013
- City of Hope
- David Horne
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUND FOR TREATING CANCER AND DIABETES
- Publication number 20220023240
- Publication date Jan 27, 2022
- CITY OF HOPE
- Samuel RAHBAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE
- Publication number 20190161461
- Publication date May 30, 2019
- CITY OF HOPE
- David Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE
- Publication number 20180155303
- Publication date Jun 7, 2018
- CITY OF HOPE
- David Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE
- Publication number 20170137392
- Publication date May 18, 2017
- CITY OF HOPE
- David Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUND FOR TREATING CANCER AND DIABETES
- Publication number 20160354327
- Publication date Dec 8, 2016
- CITY OF HOPE
- Samuel RAHBAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE
- Publication number 20160122308
- Publication date May 5, 2016
- CITY OF HOPE
- David Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE
- Publication number 20150087844
- Publication date Mar 26, 2015
- CITY OF HOPE
- David Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL MODULATORS OF DEVELOPMENT OF ADIPOCYTE AND CANCER CELLS
- Publication number 20140162996
- Publication date Jun 12, 2014
- CITY OF HOPE
- Samuel RAHBAR
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ISATIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHOD...
- Publication number 20130225637
- Publication date Aug 29, 2013
- David A. Horne
- C07 - ORGANIC CHEMISTRY
Information Patent Application
RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE
- Publication number 20120253048
- Publication date Oct 4, 2012
- Yun Yen
- C07 - ORGANIC CHEMISTRY

Christopher Lincoln

Person

Patents Grantslast 30 patents

Compound for treating cancer and diabetes

Ribonucleotide reductase inhibitors and methods of use

Modulators of development of adipocyte and cancer cells

Isatin derivatives, pharmaceutical compositions thereof, and method...

Compound for treating cancer and diabetes

Ribonucleotide reductase inhibitors and methods of use

Ribonucleotide reductase inhibitors and methods of use

Ribonucleotide reductase inhibitors and methods of use

Ribonucleotide reductase inhibitors and methods of use

Ribonucleotide reductase inhibitors and methods of use

Patents Applicationslast 30 patents

COMPOUND FOR TREATING CANCER AND DIABETES

RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE

RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE

RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE

COMPOUND FOR TREATING CANCER AND DIABETES

RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE

RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE

NOVEL MODULATORS OF DEVELOPMENT OF ADIPOCYTE AND CANCER CELLS

ISATIN DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHOD...

RIBONUCLEOTIDE REDUCTASE INHIBITORS AND METHODS OF USE